Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2003 by Facet Biotech.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Facet Biotech
Information provided by:
Facet Biotech
ClinicalTrials.gov Identifier:
NCT00032279
First received: March 15, 2002
Last updated: June 23, 2005
Last verified: October 2003
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given